Erschienen in:

01.12.2005 | Original Articles

A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)

verfasst von: Joan Maurel Santasusana, José Luis García López, Juan José Bretón García, Ana Isabel León Carbonero, Javier Gallego Plazas, Pedro Sánchez Rovira, Carlos Fernández Martos, Ma Carmen Galán Guzmán, Jesús Florián Jericó, Francisco Javier Dorta Delgado, Javier Casinello Espinosa, Marta Llanos Muñoz, Enrique Aranda Aguilar, Javier Sastre Valera, Ignacio García Ribas, Alfredo Carrato Mena

Erschienen in: Clinical and Translational Oncology | Ausgabe 11/2005